Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|2900-2908

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 2900-2908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Myeloid Leukemia

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenomics in acute myeloid leukemia

By Roumier Christophe   Cheok Meyling H  

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1839-1851

Future Medicine

Access to resources Recommend Favorite

Immunotherapy in acute myeloid leukemia

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2689-2704

Blackwell Publishing

Access to resources Recommend Favorite

Immunotherapy of Acute Myeloid Leukemia

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite

Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia

By Qu Shuang   Liu Bin   Guo Xiaoling   Shi Hongshun   Zhou Meifeng   Li Li   Yang Shulan   Tong Xiuzhen   Wang Haihe  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2130-2141

Blackwell Publishing

Access to resources Recommend Favorite